These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 18830928

  • 1. BiovaxID, a personalized therapeutic vaccine against B-cell lymphomas.
    Reinis M.
    Curr Opin Mol Ther; 2008 Oct; 10(5):526-34. PubMed ID: 18830928
    [Abstract] [Full Text] [Related]

  • 2. Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma.
    Timmerman JM, Singh G, Hermanson G, Hobart P, Czerwinski DK, Taidi B, Rajapaksa R, Caspar CB, Van Beckhoven A, Levy R.
    Cancer Res; 2002 Oct 15; 62(20):5845-52. PubMed ID: 12384547
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic lymphoma vaccines: importance of T-cell immunity.
    Neelapu SS, Lee ST, Qin H, Cha SC, Woo AF, Kwak LW.
    Expert Rev Vaccines; 2006 Jun 15; 5(3):381-94. PubMed ID: 16827622
    [Abstract] [Full Text] [Related]

  • 4. Phase I trial of a novel intradermal idiotype vaccine in patients with advanced B-cell lymphoma: specific immune responses despite profound immunosuppression.
    Bertinetti C, Zirlik K, Heining-Mikesch K, Ihorst G, Dierbach H, Waller CF, Veelken H.
    Cancer Res; 2006 Apr 15; 66(8):4496-502. PubMed ID: 16618777
    [Abstract] [Full Text] [Related]

  • 5. BiovaxID idiotype vaccination: active immunotherapy for follicular lymphoma.
    Flowers CR.
    Expert Rev Vaccines; 2007 Jun 15; 6(3):307-17. PubMed ID: 17542746
    [Abstract] [Full Text] [Related]

  • 6. Translational development of vaccination strategies in follicular NHL.
    Sakamaki I, Qin H, Kwak LW.
    Best Pract Res Clin Haematol; 2011 Jun 15; 24(2):295-304. PubMed ID: 21658625
    [Abstract] [Full Text] [Related]

  • 7. Recombinant, tumour-derived idiotype vaccination for indolent B cell non-Hodgkin's lymphomas: a focus on FavId.
    Hurvitz SA, Timmerman JM.
    Expert Opin Biol Ther; 2005 Jun 15; 5(6):841-52. PubMed ID: 15952914
    [Abstract] [Full Text] [Related]

  • 8. Plant-produced idiotype vaccines for the treatment of non-Hodgkin's lymphoma: safety and immunogenicity in a phase I clinical study.
    McCormick AA, Reddy S, Reinl SJ, Cameron TI, Czerwinkski DK, Vojdani F, Hanley KM, Garger SJ, White EL, Novak J, Barrett J, Holtz RB, Tusé D, Levy R.
    Proc Natl Acad Sci U S A; 2008 Jul 22; 105(29):10131-6. PubMed ID: 18645180
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Personalized immunotherapy for the treatment of non-Hodgkin's lymphoma: a promising approach.
    Vose JM.
    Hematol Oncol; 2006 Jun 22; 24(2):47-55. PubMed ID: 16447298
    [Abstract] [Full Text] [Related]

  • 11. Lymphoma vaccine trial: one step forward in long trek.
    Schmidt C.
    J Natl Cancer Inst; 2009 Sep 16; 101(18):1228-9, 1232. PubMed ID: 19738162
    [No Abstract] [Full Text] [Related]

  • 12. Phase III randomized study of autologous lymphoma-derived idiotype specific vaccination plus GM-CSF in patients with follicular lymphoma in first complete remission.
    Clin Adv Hematol Oncol; 2003 Jan 16; 1(1):67. PubMed ID: 16227966
    [No Abstract] [Full Text] [Related]

  • 13. The role of idiotype vaccines in the treatment of human B-cell malignancies.
    Bendandi M.
    Expert Rev Vaccines; 2004 Apr 16; 3(2):163-70. PubMed ID: 15056042
    [Abstract] [Full Text] [Related]

  • 14. Personalized immunotherapy for the treatment of non-Hodgkin lymphoma: a promising approach.
    Vose J.
    Clin Adv Hematol Oncol; 2005 Dec 16; 3(12):923-32. PubMed ID: 16555434
    [Abstract] [Full Text] [Related]

  • 15. Cloning of idiotype immunoglobulin genes in B cell lymphomas by anchored PCR and production of individual recombinant idiotype vaccines in Escherichia coli.
    Bertinetti C, Simon F, Zirlik K, Heining-Mikesch K, Pfeifer D, Osterroth F, Rosenthal FM, Veelken H.
    Eur J Haematol; 2006 Nov 16; 77(5):395-402. PubMed ID: 16879605
    [Abstract] [Full Text] [Related]

  • 16. Vaccines for lymphomas: idiotype vaccines and beyond.
    Houot R, Levy R.
    Blood Rev; 2009 May 16; 23(3):137-42. PubMed ID: 18951668
    [Abstract] [Full Text] [Related]

  • 17. Cancer vaccine strategies get bigger and better.
    de Gruijl TD, Curiel DT.
    Nat Med; 1999 Oct 16; 5(10):1124-5. PubMed ID: 10502808
    [No Abstract] [Full Text] [Related]

  • 18. BiovaxID: a personalized therapeutic cancer vaccine for non-Hodgkin's lymphoma.
    Lee ST, Jiang YF, Park KU, Woo AF, Neelapu SS.
    Expert Opin Biol Ther; 2007 Jan 16; 7(1):113-22. PubMed ID: 17150023
    [Abstract] [Full Text] [Related]

  • 19. [Treatment strategy for indolent B-cell lymphoma].
    Tobinai K.
    Rinsho Ketsueki; 2001 Apr 16; 42(4):288-92. PubMed ID: 11400299
    [No Abstract] [Full Text] [Related]

  • 20. Role of anti-idiotype vaccines in the modern treatment of human follicular lymphoma.
    Bendandi M.
    Expert Rev Anticancer Ther; 2001 Jun 16; 1(1):65-72. PubMed ID: 12113135
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.